Clinical Trial Results: Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled trial evaluating valganciclovir for cytomegalovirus-infected infants with hearing impairment has terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Congenital Infection
• Sensorineural Hearing Loss

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Albert Park | Conditions: Cmv Congenital, CMV | Phase 2 | Status: TERMINATED | Results posted: 2026-08-27